Predictors of uncontrolled hypertension in the stroke belt

Journal of Clinical Hypertension

Volumn 15, Issue 8, 2013, Pages 562-569

  Dave, Gaurav J ^a   Bibeau, Daniel L ^b   Schulz, Mark R ^b   Aronson, Robert E ^b   Ivanov, Louise L ^b   Black, Adina ^a   Spann, Lapronda ^c  

^a North Carolina Translational and Clinical Sciences Institute   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^c FORSYTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AFRICAN AMERICAN; ANTIHYPERTENSIVE THERAPY; ARTICLE; CAUCASIAN; CEREBROVASCULAR ACCIDENT; DIASTOLIC BLOOD PRESSURE; DIASTOLIC HYPERTENSION; GROUPS BY AGE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PREDICTIVE VALUE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING; SELF REPORT; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; TREATMENT REFUSAL; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGE FACTORS; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NORTH CAROLINA; ODDS RATIO; QUESTIONNAIRES; STROKE; TRIGLYCERIDES; YOUNG ADULT;

EID: 84880754351     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12122     Document Type: Article

References (56)

1. Heron MP, Hoyert DL, Murphy SL, et al. Final data for 2006. National Center for Health Statistics. Natl Vital Stat Rep. 2009;57:1-134.
2. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics-2009 update a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:480-486.
3. The Centers for Disease Control and Prevention. Health, United States, 2008, With Special Feature on the Health of Young Adults. Hyattsville, MD: National Center for Health Statistics; 2009. Available at: http://www.cdc.gov/nchs/hus.htm. Accessed September 1, 2011.
4. Chobanian AV, Bakris GL, Black HR, et al; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
5. National Heart, Lung and Blood Institute. National High Blood Pressure Education Program: Program Description. Available at: http://www.nhlbi.nih.gov/about/nhbpep/nhbp_pd.htm. Accessed September 1, 2011.
6. Gu Q, Burt VL, Dillon CF, Yoon S. Trends in antihypertensive medication use and blood pressure control among united states adults with hypertensionclinical perspective the national health and nutrition examination survey, 2001 to 2010. Circulation. 2012;126:2105-2114.
7. Angell SY, Garg RK, Gwynn RC, et al. Prevalence, awareness, treatment, and predictors of control of hypertension in New York City. Circ Cardiovasc Qual Outcomes. 2008;1:46-53.
8. Aronow WS, Fleg JL, Pepine CJ, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Coll Cardiol. 2011;57:2037-2114.
9. Franklin SS, Larson MG, Khan SA, et al. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation. 2001;103:1245-1249.
10. Nasir K, McClelland RL, Blumenthal RS, et al. Coronary artery calcium in relation to initiation and continuation of cardiovascular preventive medications the Multi-Ethnic Study of Atherosclerosis (MESA). Circ Cardiovasc Qual Outcomes. 2010;3:228-235.
11. Keyhani S, Scobie JV, Hebert PL, McLaughlin MA. Gender disparities in blood pressure control and cardiovascular care in a national sample of ambulatory care visits. Hypertension. 2008;51:1149-1155.
12. Olomu AB, Gourineni V, Huang JL, et al. Rate and predictors of blood pressure control in a Federal Qualified Health Center in Michigan: a huge concern? J Clin Hypertens. 2013;15:254-263.
13. Shirani S, Gharipour M, Khosravi A, et al. Gender differences in the prevalence of hypertension in a representative sample of Iranian population: the Isfahan Healthy Heart Program. Acta Biomed. 2011;82:223.
14. Krousel-Wood MA, Muntner P, Islam T, et al. Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults. Med Clin North Am. 2009;93:753-769.
15. Vawter L, Tong X, Gemilyan M, Yoon PW. Barriers to antihypertensive medication adherence among adults-United States, 2005. J Clin Hypertens. 2008;10:922-929.
16. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345:479-486.
17. Hyman DJ, Pavlik VN. Poor hypertension control: let's stop blaming the patients. Cleve Clin J Med. 2002;69:793-799.
18. Izzo JL, Levy D, Black HR. Importance of systolic blood pressure in older americans. Hypertension. 2000;35:1021-1024.
19. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the health examination surveys, 1960 to 1991. Hypertension. 1995;26:60-69.
20. Franklin SS, Gustin W, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997;96:308-315.
21. Degoulet P, Menard J, Vu H, et al. Factors predictive of attendance at clinic and blood pressure control in hypertensive patients. BMJ. 1983;287:88-93.
22. Kotchen TA. The search for strategies to control hypertension. Circulation. 2010;122:1141-1143.
23. Knight EL, Bohn RL, Wang PS, et al. Predictors of uncontrolled hypertension in ambulatory patients. Hypertension. 2001;38:809-814.
24. Redon J, Erdine S, Boehm M, et al. Investigating the critical situation in hypertension management: is physician inertia putting patients at increased cardiovascular risk? (Share Survey): 4B. 06. J Hypertens. 2010;28:e210-e211.
25. Redon J, Erdine S, Böhm M, et al. Physician attitudes to blood pressure control: findings from the Supporting Hypertension Awareness and Research Europe-wide survey. J Hypertens. 2011;29:1633-1640.
26. Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:1957-1963.
27. Persell SD. Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension. 2011;57:1076-1080.
28. Pimenta E, Calhoun DA. Resistant hypertension incidence, prevalence, and prognosis. Circulation. 2012;125:1594-1596.
29. Benetos A, Gautier S, Labat C, et al. Mortality and cardiovascular events are best predicted by low central/peripheral pulse pressure amplification but not by high blood pressure levels in elderly nursing home subjects: the PARTAGE (Predictive Values of Blood Pressure and Arterial Stiffness in Institutionalized Very Aged Population) study. J Am Coll Cardiol. 2012;60:1503-1511.
30. Ogedegbe G. Barriers to optimal hypertension control. J Clin Hypertens. 2008;10:644-646.
31. Wang TJ, Vasan RS. Epidemiology of uncontrolled hypertension in the United States. Circulation. 2005;112:1651-1662.
32. Fernandez S, Tobin JN, Cassells A, et al. The counseling African Americans to Control Hypertension (CAATCH) Trial: baseline demographic, clinical, psychosocial, and behavioral characteristics. Implement Sci. 2011;6:100.
33. Turner BJ, Hollenbeak C, Weiner MG, et al. Barriers to adherence and hypertension control in a racially diverse representative sample of elderly primary care patients. Pharmacoepidemiol Drug Saf. 2009;18:672-681.
34. Fletcher SW, Deliakis J, Schoch WA, Shapiro SH. Predicting blood pressure control in hypertensive patients: an approach to quality-of-care assessment. Med Care. 1979;17:285-292.
35. Cushman W, Ford C, Cutler J, et al. ALLHAT Collaborative Research Group: success and predictors of blood pressure control in diverse North American settings: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens. 2002;4:393-404.
36. Levine DA, Lewis CE, Williams OD, et al. Geographic and demographic variability in 20-year hypertension incidence the CARDIA study. Hypertension. 2011;57:39-47.
37. Russell C, Conn V, Jantarakupt P. Older adult medication compliance: integrated review of randomized controlled trials. Am J Health Behav. 2006;30:636-650.
38. Miller E, Schulz MR, Bibeau DL, et al. Factors associated with misperceptions of weight in the stroke belt. J Gen Intern Med. 2008;23:323-328.
39. Groh MR. Access 2010 Bible. Indianapolis, IN: Wiley Publishing Inc; 2010.
40. Norusis M, SPSS Inc. PASW Statistics 18 Guide to Data Analysis. Upper Saddle River, NJ: Pearson; 2011.
41. Bersamin A, Stafford RS, Winkleby MA. Predictors of hypertension awareness, treatment, and control among Mexican American women and men. J Gen Intern Med. 2009;24:521-527.
42. Morgado M, Rolo S, Macedo AF, et al. Predictors of uncontrolled hypertension and antihypertension medication adherence. J Cardiovasc Dis Res. 2011;1:196-202.
43. Fongwa MN, Evangelista LS, Hays RD, et al. Adherence treatment factors in hypertensive African American women. Vasc Health Risk Manag. 2008;4:157-166.
44. Ogedegbe G, Harrison M, Robbins L, et al. Barriers and facilitators of medication adherence in hypertensive African Americans: a qualitative study. Ethn Dis. 2004;14:3-12.
45. Clark LT. Improving compliance and increasing control of hypertension: needs of special hypertensive populations. Am Heart J. 1991;12:664-669.
46. Boutin-Foster C, Ogedegbe G, Ravenell JE, et al. Ascribing meaning to hypertension: a qualitative study among African Americans with uncontrolled hypertension. Ethn Dis. 2007;17:29-34.
47. Doshi JA, Zuckerman IH, Picot SJ, et al. Antihypertensive use and adherence and blood pressure stress response among black caregivers and noncaregivers. Appl Nurs Res. 2003;16:266-277.
48. Krousel-Wood M, Hyre A, Muntner P, et al. Methods to improve medication adherence in patients with hypertension: current status and future directions. Curr Opin Cardiol. 2005;20:296-300.
49. Wong ND, Lopez VA, L'Italien G, et al. Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004. Arch Intern Med. 2007;167:2431-2436.
50. Hyman D, Pavlik V, Vallbona C. Physician role in lack of awareness and control of hypertension. J Clin Hypertens. 2000;2:324-330.
51. Nash DT. Systolic hypertension - combination therapy as one approach to treating a persistent condition. Geriatrics. 2006;61:22-28.
52. Marshall TP. Blood pressure variability: the challenge of variation. Am J Hypertens. 2008;21:3-4.
53. Hajjar I, Kotchen JM, Kotchen TA. Hypertension: trends in prevalence, incidence and control. Annu Rev Public Health. 2006;27:465-490.
54. Krum H, Jelinek MV, Stewart S, et al. Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006. Med J Aust. 2006;185:549-556.
55. Taylor A, Pickering S, Grant J, et al. Comparing self-reported and measured high blood pressure and high cholesterol status using data from a large representative cohort study. Aust N Z J Public Health. 2010;34:394-400.
56. Turner MJ, van Schalkwyk JM. Blood pressure variability causes identification of hypertension in clinical studies: a computer simulation study. Am J Hypertens. 2008;21:85-91.